Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Translational Psychiatry
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. translational psychiatry
  3. articles
  4. article
Fecal metaproteomics reveals alterations in gut microbiota and intestinal proteins in adolescents with bipolar depression
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 14 February 2026

Fecal metaproteomics reveals alterations in gut microbiota and intestinal proteins in adolescents with bipolar depression

  • Zixuan Zhao1,2 na1,
  • Fan Yang3 na1,
  • Yuwen Tan2 na1,
  • Xiaoqing Yin1,
  • Xueying Li1,
  • Qixiao Lin2,
  • Fangfang Zheng3,
  • Jihui Yue1 &
  • …
  • Yong Lin  ORCID: orcid.org/0000-0002-9345-19801 

Translational Psychiatry , Article number:  (2026) Cite this article

  • 7 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Biomarkers
  • Bipolar disorder

Abstract

This study aims to compare the gut microbiota and the profiles of human and microbial proteins in adolescents with bipolar depression (BD) and healthy controls (HCs), as well as to investigate the potential of gut-derived proteins as biomarkers for BD diagnosis. Fecal samples were collected from 15 adolescents with depressive episodes of BD and 58 healthy individuals, and fecal metaproteomics was used to assess changes in the gut environment. The results revealed an increased abundance of gut bacteria associated with lactate production and metabolism, such as Bifidobacteriaceae and Megasphaera, in BD patients. Additionally, there was a higher abundance of Alistipes, a bacterium linked to stress. Notably, the host proteins CELA2A, DEFA3, and KLK1 achieved high ROC-AUC values (0.905, 0.897, and 0.897) and PR-AUC values (0.978, 0.975, and 0.975),indicating their potential as diagnostic biomarkers for BD. In conclusion, we observed an increased abundance of Bifidobacteriaceae, Megasphaera, and Alistipes in adolescents with BD. We propose that CELA2A, DEFA3, and KLK1 could be potential biomarkers for BD, although further validation is required.

Similar content being viewed by others

Metaproteomic portrait of the healthy human gut microbiota

Article Open access 28 June 2024

Alterations in fecal microbiota composition and cytokine expression profiles in adolescents with depression: a case-control study

Article Open access 09 April 2025

Dysbiosis and depression: A study of gut microbiota alterations and functional pathways in antidepressant-naïve mood disorder patients

Article Open access 18 August 2025

Data availability

The mass spectrometry data generated in this study have been deposited in the Integrated Proteome Resources (iProX) database with the dataset identifier IPX0013607000. The data are publicly available at https://www.iprox.cn/page/project.html?id=IPX0013607000 and via the ProteomeXchange Consortium under the identifier PXD068942.

References

  1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22.

    Google Scholar 

  2. Bolton S, Warner J, Harriss E, Geddes J, Saunders KEA. Bipolar disorder: Trimodal age-at-onset distribution. Bipolar Disord. 2021;23:341–56.

    Google Scholar 

  3. Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387:1561–72.

    Google Scholar 

  4. Kapczinski F, Montezano BB, de Azevedo Cardoso T. Latent bipolar disorder. Lancet. 2023;401:2109.

    Google Scholar 

  5. Wells JM, Brummer RJ, Derrien M, MacDonald TT, Troost F, Cani PD, et al. Homeostasis of the gut barrier and potential biomarkers. Am J Physiol Gastrointest Liver Physiol. 2017;312:G171–93.

    Google Scholar 

  6. Knuesel T, Mohajeri MH. The role of the gut microbiota in the development and progression of major depressive and bipolar disorder. Nutrients. 2021;14:37.

    Google Scholar 

  7. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–94.

    Google Scholar 

  8. Xu K, Ren Y, Zhao S, Feng J, Wu Q, Gong X, et al. Oral D-ribose causes depressive-like behavior by altering glycerophospholipid metabolism via the gut-brain axis. Commun Biol. 2024;7:69.

    Google Scholar 

  9. Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, et al. Bifidobacterium and Lactobacillus counts in the gut microbiota of patients with bipolar disorder and healthy controls. Front Psychiatry. 2019;9:730.

    Google Scholar 

  10. Chen YH, Zhou CH, Yu H, Wu WJ, Wang YW, Liu L, et al. Gut microbial signatures and differences in bipolar disorder and schizophrenia of emerging adulthood. CNS Neurosci Ther. 2023;29:5–17.

    Google Scholar 

  11. Evans SJ, Bassis CM, Hein R, Assari S, Flowers SA, Kelly MB, et al. The gut microbiome composition associates with bipolar disorder and illness severity. J Psychiatr Res. 2017;87:23–29.

    Google Scholar 

  12. Cui M, Cheng C, Zhang L. High-throughput proteomics: a methodological mini-review. Lab Invest. 2022;102:1170–81.

    Google Scholar 

  13. Gabriele C, Aracri F, Prestagiacomo LE, Rota MA, Alba S, Tradigo G, et al. Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables. Clin Proteomics. 2023;20:52.

    Google Scholar 

  14. Liu Y, Wang H, Gui S, Zeng B, Pu J, Zheng P, et al. Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression. Transl Psychiatry. 2021;11:568.

    Google Scholar 

  15. Göteson A, Isgren A, Jonsson L, Sparding T, Smedler E, Pelanis A, et al. Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder. Mol Psychiatry. 2021;26:7446–53.

    Google Scholar 

  16. Li Z, Lai J, Zhang P, Ding J, Jiang J, Liu C, et al. Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depression. Mol Psychiatry. 2022;27:4123–35.

    Google Scholar 

  17. Zou Y, Xue W, Luo G, Deng Z, Qin P, Guo R, et al. 1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses. Nat Biotechnol. 2019;37:179–85.

    Google Scholar 

  18. Browne HP, Forster SC, Anonye BO, Kumar N, Neville BA, Stares MD, et al. Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature. 2016;533:543–6.

    Google Scholar 

  19. Zhou L, Wang M, Liu S, Gu L, Liu S, Du Q, et al. KLK1 as an epithelial-specific brake inhibits colorectal tumorigenesis by suppressing B1R-Mediated fibroblast phenotypic transition. Adv Sci (Weinh). Published online August 26, 2025.

  20. Thompson AGB, Anastasiadis P, Druyeh R, Whitworth I, Nayak A, Nihat A, et al. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Mol Psychiatry. 2021;26:5955–66.

    Google Scholar 

  21. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjöberg J, Amir E, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 2010;11:76–83.

    Google Scholar 

  22. Hu S, Li A, Huang T, Lai J, Li J, Sublette ME, et al. Gut microbiota changes in patients with bipolar depression. Adv Sci (Weinh). 2019;6:1900752.

    Google Scholar 

  23. Parkar SG, Rosendale DI, Stoklosinski HM, Jobsis CMH, Hedderley DI, Gopal P. Complementary food ingredients alter infant gut microbiome composition and metabolism in vitro. Microorganisms. 2021;9:2089.

    Google Scholar 

  24. McGuinness AJ, Davis JA, Dawson SL, Loughman A, Collier F, O’Hely M, et al. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry. 2022;27:1920–35.

    Google Scholar 

  25. Wang M, Song Z, Lai S, Tang F, Dou L, Yang F. Depression-associated gut microbes, metabolites and clinical trials. Front Microbiol. 2024;15:1292004.

    Google Scholar 

  26. Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19:29–41.

    Google Scholar 

  27. Fang X, Wang Z, Chen Q, Du Y, Sun H, Liu H, et al. Protective effect of the branched short-chain fatty acid isobutyrate on intestinal damage in weaned piglets through intestinal microbiota remodeling. J Sci Food Agric. 2025;105:1556–68.

    Google Scholar 

  28. Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K, Clarke G, et al. Targeting the microbiota-gut-brain axis: Prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry. 2017;82:472–87.

    Google Scholar 

  29. Cheng J, Hu H, Ju Y, Liu J, Wang M, Liu B, et al. Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications. Gen Psychiatr. 2024;37:e101374.

    Google Scholar 

  30. Hernández-Cacho A, García-Gavilán JF, Atzeni A, Konstanti P, Belzer C, Vioque J, et al. Multi-omics approach identifies gut microbiota variations associated with depression. NPJ Biofilms Microbiomes. 2025;11:68.

    Google Scholar 

  31. Wang D, Eraslan B, Wieland T, Hallström B, Hopf T, Zolg DP, et al. A deep proteome and transcriptome abundance atlas of 29 healthy human tissues. Mol Syst Biol. 2019;15:e8503.

    Google Scholar 

  32. Bucatoş BO, Gaita L, Romoşan AM, Papava I, Popovici M, Romoşan RŞ, et al. Coping Strategies in Patients with Bipolar Disorder (BD) and Major Depressive Disorder (MDD) and their correlation with clusters of psychiatric symptoms. Healthcare (Basel). 2025;13:1050.

    Google Scholar 

  33. Gao K, Calabrese JR. Prevalence and factors associated with fatigue in patients with major depressive disorder or bipolar disorder. J Affect Disord. 2024;362:493–501.

    Google Scholar 

  34. Frémont M, Coomans D, Massart S, De Meirleir K. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients. Anaerobe. 2013;22:50–56.

    Google Scholar 

  35. Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linløkken A, Wilson R, et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26:1155–62.

    Google Scholar 

  36. Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The Genus Alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol. 2020;11:906.

    Google Scholar 

  37. Guo XJ, Xiong YB, Jia Y, Cui XH, Wu WZ, Tian JS, et al. Altered metabolomics in bipolar depression with gastrointestinal symptoms. Front Psychiatry. 2022;13:861285.

    Google Scholar 

  38. Guo Z, Xiao S, Chen G, Zhong S, Zhong H, Sun S, et al. Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression. Transl Psychiatry. 2024;14:495.

    Google Scholar 

  39. Ludvigsson JF, Olén O, Larsson H, Halfvarson J, Almqvist C, Lichtenstein P, et al. Association between inflammatory bowel disease and psychiatric morbidity and suicide: A Swedish nationwide population-based cohort study with sibling comparisons. J Crohns Colitis. 2021;15:1824–36.

    Google Scholar 

  40. Yoon H, Schaubeck M, Lagkouvardos I, Blesl A, Heinzlmeir S, Hahne H, et al. Increased pancreatic protease activity in response to antibiotics impairs gut barrier and triggers colitis. Cell Mol Gastroenterol Hepatol. 2018;6:370–88.e3.

    Google Scholar 

  41. Zhang S, Nie Q, Sun Y, Zuo S, Chen C, Li S, et al. Bacteroides uniformis degrades β-glucan to promote Lactobacillus johnsonii improving indole-3-lactic acid levels in alleviating colitis. Microbiome. 2024;12:177.

    Google Scholar 

  42. Hao Z, Meng C, Li L, Feng S, Zhu Y, Yang J, et al. Positive mood-related gut microbiota in a long-term closed environment: A multiomics study based on the “Lunar Palace 365” experiment. Microbiome. 2023;11:88.

    Google Scholar 

  43. Xu D, Lu W. Defensins: A double-edged sword in host immunity. Front Immunol. 2020;11:764.

    Google Scholar 

  44. Suzuki K, Nakamura K, Shimizu Y, Yokoi Y, Ohira S, Hagiwara M, et al. Decrease of α-defensin impairs intestinal metabolite homeostasis via dysbiosis in mouse chronic social defeat stress model. Sci Rep. 2021;11:9915.

    Google Scholar 

  45. Di Renzo L, Frank G, Pala B, Cianci R, La Placa G, Raffaelli G, et al. Effects of Italian mediterranean organic diet on the gut microbiota: A pilot comparative study with conventional products and free diet. Microorganisms. 2025;13:1694.

    Google Scholar 

  46. Sun N, Zhang J, Wang J, Liu Z, Wang X, Kang P, et al. Abnormal gut microbiota and bile acids in patients with first-episode major depressive disorder and correlation analysis. Psychiatry Clin Neurosci. 2022;76:321–8.

    Google Scholar 

Download references

Author information

Author notes
  1. These authors contributed equally: Zixuan Zhao, Fan Yang, Yuwen Tan.

Authors and Affiliations

  1. Department of Psychiatry and Psychology, the Fifth Affiliated Hospital, SunYat-Sen University, Zhuhai, 519000, China

    Zixuan Zhao, Xiaoqing Yin, Xueying Li, Jihui Yue & Yong Lin

  2. Centerof Molecular Imaging, the Fifth Affiliated Hospital, SunYat-Sen University, Zhuhai, 519000, China

    Zixuan Zhao, Yuwen Tan & Qixiao Lin

  3. Department of Pediatrics, the Fifth Affiliated Hospital, SunYat-Sen University, Zhuhai, 519000, China

    Fan Yang & Fangfang Zheng

Authors
  1. Zixuan Zhao
    View author publications

    Search author on:PubMed Google Scholar

  2. Fan Yang
    View author publications

    Search author on:PubMed Google Scholar

  3. Yuwen Tan
    View author publications

    Search author on:PubMed Google Scholar

  4. Xiaoqing Yin
    View author publications

    Search author on:PubMed Google Scholar

  5. Xueying Li
    View author publications

    Search author on:PubMed Google Scholar

  6. Qixiao Lin
    View author publications

    Search author on:PubMed Google Scholar

  7. Fangfang Zheng
    View author publications

    Search author on:PubMed Google Scholar

  8. Jihui Yue
    View author publications

    Search author on:PubMed Google Scholar

  9. Yong Lin
    View author publications

    Search author on:PubMed Google Scholar

Contributions

ZZ and LY conceived and designed the study. YJ, FY, TY, YX, LX and LQ recruited participants and collected clinical samples. ZZ and TY performed data analysis and interpretation. ZZ drafted the original manuscript. YF, ZF and LY critically reviewed and revised the manuscript. LY supervised the study and acquired funding. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Fangfang Zheng, Jihui Yue or Yong Lin.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

All procedures performed in this study were conducted in accordance with the relevant guidelines and regulations. The study was approved by the Ethics Committee of The Fifth Affiliated Hospital of Sun Yat-sen University (Approval No. 2020-K32-1). Written informed consent was obtained from all participants and their legal guardians prior to participation in the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Figure S1

Figure S2

Supplementary material legends

Table S1

Table S2

Table S3

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, Z., Yang, F., Tan, Y. et al. Fecal metaproteomics reveals alterations in gut microbiota and intestinal proteins in adolescents with bipolar depression. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-03899-6

Download citation

  • Received: 20 May 2025

  • Revised: 23 December 2025

  • Accepted: 01 February 2026

  • Published: 14 February 2026

  • DOI: https://doi.org/10.1038/s41398-026-03899-6

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open Access Publishing
  • About the Editors
  • Contact
  • For Advertisers
  • Calls for Papers
  • Press Releases

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Translational Psychiatry (Transl Psychiatry)

ISSN 2158-3188 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited